Cargando…

Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies

Ovarian cancers include several disease subtypes and patients often present with advanced metastatic disease and a poor prognosis. New biomarkers for early diagnosis and targeted therapy are, therefore, urgently required. This study uses antibodies produced locally in tumor-draining lymph nodes (ASC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Gama Duarte, Jessica, Quigley, Luke T., Young, Anna Rachel, Hayashi, Masaru, Miyazawa, Mariko, Lopata, Alex, Mancuso, Nunzio, Mikami, Mikio, Behren, Andreas, Meeusen, Els
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538754/ https://www.ncbi.nlm.nih.gov/pubmed/34681879 http://dx.doi.org/10.3390/ijms222011220

Ejemplares similares

Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes
por: Young, Anna Rachel, et al.
Publicado: (2019)

Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008)

Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA): A Potential New Tool for Early Detection of Ovarian Cancer
por: Hayashi, Masaru, et al.
Publicado: (2019)

UPLC-MS/MS based diagnostics for epithelial ovarian cancer using fully sialylated C4-binding protein
por: Tanabe, Kazuhiro, et al.
Publicado: (2018)

γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
por: Chan, Kok Fei, et al.
Publicado: (2022)

Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
por: Shida, Masako, et al.
Publicado: (2016)

Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry
por: Quigley, Luke T., et al.
Publicado: (2023)

An Up-to-Date Anti-Cancer Treatment Strategy Focusing on HIF-1α Suppression: Its Application for Refractory Ovarian Cancer
por: Fujita, Mariko, et al.
Publicado: (2007)

Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma
por: Mikami, Mikio, et al.
Publicado: (2015)

Role of lymphadenectomy for ovarian cancer
por: Mikami, Mikio
Publicado: (2014)

Enhanced expression of hydroxylated ceramide in well-differentiated endometrial adenocarcinoma
por: Tajima, Toshiki, et al.
Publicado: (2017)

Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012)

The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination
por: Szczerba, Anna, et al.
Publicado: (2022)

Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2021)

Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
por: Nagamine, Michiko, et al.
Publicado: (2020)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma
por: Piura, Benjamin, et al.
Publicado: (2009)

Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer
por: Jie, Xiaoxiang, et al.
Publicado: (2022)

Presence and diagnostic value of circulating tsncRNA for ovarian tumor
por: Peng, Eric Y., et al.
Publicado: (2018)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Immunologic aspect of ovarian cancer and p53 as tumor antigen
por: Nijman, HW, et al.
Publicado: (2005)

Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2020)

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
por: Yang, Fang, et al.
Publicado: (2021)

Ovarian conservation for young women with clinical stage IB–IIB cervical cancer in Japan
por: Matsuo, Koji, et al.
Publicado: (2017)

Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
por: Kfoury, Maria, et al.
Publicado: (2023)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach
por: McWilliam, Hamish EG, et al.
Publicado: (2014)

Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma
por: Harasawa, Makiko, et al.
Publicado: (2011)

Comprehensive Serum Glycopeptide Spectra Analysis Combined with Artificial Intelligence (CSGSA-AI) to Diagnose Early-Stage Ovarian Cancer
por: Tanabe, Kazuhiro, et al.
Publicado: (2020)

Expression of Tumor‐rejection Antigens in Gynecologic Cancers
por: Tanaka, Shoko, et al.
Publicado: (2000)

A Case of Uterine Tumor Resembling Ovarian Sex-cord Tumor (UTROSCT) Exhibiting Similar Imaging Characteristics to Those of Ovarian Sex-cord Tumor
por: Takeuchi, Mayumi, et al.
Publicado: (2018)

Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis
por: Zhou, Yunlan, et al.
Publicado: (2015)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Lu, Yuanyuan, et al.
Publicado: (2021)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2023)

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
por: Klein, Oliver, et al.
Publicado: (2021)

Tumor Hypoxia and Circulating Tumor Cells
por: Tinganelli, Walter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9mpjih1plgp5oovr0puejjglk